Cargando…

Esophageal abnormalities and the risk for gastroesophageal cancers—a histopathology-register-based study in Sweden

BACKGROUND: The poor survival of patients with gastroesophageal cancers may improve if additional esophageal precursor lesions to Barrett’s esophagus and squamous dysplasia are identified. We estimated the risk for gastroesophageal cancers among patients with various histopathological abnormalities...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekheden, Isabella, Ludvigsson, Jonas F., Yin, Li, Elbe, Peter, Ye, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187549/
https://www.ncbi.nlm.nih.gov/pubmed/34978667
http://dx.doi.org/10.1007/s10654-021-00833-6
_version_ 1784725196070977536
author Ekheden, Isabella
Ludvigsson, Jonas F.
Yin, Li
Elbe, Peter
Ye, Weimin
author_facet Ekheden, Isabella
Ludvigsson, Jonas F.
Yin, Li
Elbe, Peter
Ye, Weimin
author_sort Ekheden, Isabella
collection PubMed
description BACKGROUND: The poor survival of patients with gastroesophageal cancers may improve if additional esophageal precursor lesions to Barrett’s esophagus and squamous dysplasia are identified. We estimated the risk for gastroesophageal cancers among patients with various histopathological abnormalities in the esophagus, including Barrett’s esophagus, subdivided by histopathological types. METHODS: Histopathology data from esophageal biopsies obtained 1979–2014 were linked with several national population-based registers in Sweden. Patients were followed from 2 years after the first biopsy date until cancer, death, emigration, esophagectomy/gastrectomy or end of follow-up, 31st of December 2016, whichever came first. We estimated standardized incidence ratios (SIRs) as measures of relative risk with the Swedish general population as reference. RESULTS: In total 367 esophageal adenocarcinoma (EAC) cases were ascertained during 831,394 person-years of follow-up. The incidence rate (IR) for EAC was 0.1 per 1000 person-years for normal morphology, 0.2–0.5 for inflammatory changes, and 0.8–2.9 for metaplasia. The IR was 1.0 per 1000 person-years (95% confidence interval 0.7–1.3) among patients with non-dysplastic intestinal metaplasia, 0.9 (0.8–1.1) in non-dysplastic gastric/glandular metaplasia and 2.9 (2.0–4.2) among columnar metaplasia patients with low-grade dysplasia. The SIRs were 11.7 (95% confidence interval 8.6–15.5), 12.0 (10.0–14.2) and 30.2 (20.5–42.8), respectively. The SIRs for gastric cardia adenocarcinoma (GCA) were moderately elevated. CONCLUSIONS: For the first time, we demonstrate that patients with esophageal inflammatory and other metaplastic abnormalities than Barrett’s esophagus have an increased risk of EAC and GCA compared to the general population. Moreover, patients with different histopathologic subtypes of Barrett’s esophagus have a comparable risk for EAC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10654-021-00833-6.
format Online
Article
Text
id pubmed-9187549
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-91875492022-06-12 Esophageal abnormalities and the risk for gastroesophageal cancers—a histopathology-register-based study in Sweden Ekheden, Isabella Ludvigsson, Jonas F. Yin, Li Elbe, Peter Ye, Weimin Eur J Epidemiol Cancer BACKGROUND: The poor survival of patients with gastroesophageal cancers may improve if additional esophageal precursor lesions to Barrett’s esophagus and squamous dysplasia are identified. We estimated the risk for gastroesophageal cancers among patients with various histopathological abnormalities in the esophagus, including Barrett’s esophagus, subdivided by histopathological types. METHODS: Histopathology data from esophageal biopsies obtained 1979–2014 were linked with several national population-based registers in Sweden. Patients were followed from 2 years after the first biopsy date until cancer, death, emigration, esophagectomy/gastrectomy or end of follow-up, 31st of December 2016, whichever came first. We estimated standardized incidence ratios (SIRs) as measures of relative risk with the Swedish general population as reference. RESULTS: In total 367 esophageal adenocarcinoma (EAC) cases were ascertained during 831,394 person-years of follow-up. The incidence rate (IR) for EAC was 0.1 per 1000 person-years for normal morphology, 0.2–0.5 for inflammatory changes, and 0.8–2.9 for metaplasia. The IR was 1.0 per 1000 person-years (95% confidence interval 0.7–1.3) among patients with non-dysplastic intestinal metaplasia, 0.9 (0.8–1.1) in non-dysplastic gastric/glandular metaplasia and 2.9 (2.0–4.2) among columnar metaplasia patients with low-grade dysplasia. The SIRs were 11.7 (95% confidence interval 8.6–15.5), 12.0 (10.0–14.2) and 30.2 (20.5–42.8), respectively. The SIRs for gastric cardia adenocarcinoma (GCA) were moderately elevated. CONCLUSIONS: For the first time, we demonstrate that patients with esophageal inflammatory and other metaplastic abnormalities than Barrett’s esophagus have an increased risk of EAC and GCA compared to the general population. Moreover, patients with different histopathologic subtypes of Barrett’s esophagus have a comparable risk for EAC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10654-021-00833-6. Springer Netherlands 2022-01-03 2022 /pmc/articles/PMC9187549/ /pubmed/34978667 http://dx.doi.org/10.1007/s10654-021-00833-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Cancer
Ekheden, Isabella
Ludvigsson, Jonas F.
Yin, Li
Elbe, Peter
Ye, Weimin
Esophageal abnormalities and the risk for gastroesophageal cancers—a histopathology-register-based study in Sweden
title Esophageal abnormalities and the risk for gastroesophageal cancers—a histopathology-register-based study in Sweden
title_full Esophageal abnormalities and the risk for gastroesophageal cancers—a histopathology-register-based study in Sweden
title_fullStr Esophageal abnormalities and the risk for gastroesophageal cancers—a histopathology-register-based study in Sweden
title_full_unstemmed Esophageal abnormalities and the risk for gastroesophageal cancers—a histopathology-register-based study in Sweden
title_short Esophageal abnormalities and the risk for gastroesophageal cancers—a histopathology-register-based study in Sweden
title_sort esophageal abnormalities and the risk for gastroesophageal cancers—a histopathology-register-based study in sweden
topic Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187549/
https://www.ncbi.nlm.nih.gov/pubmed/34978667
http://dx.doi.org/10.1007/s10654-021-00833-6
work_keys_str_mv AT ekhedenisabella esophagealabnormalitiesandtheriskforgastroesophagealcancersahistopathologyregisterbasedstudyinsweden
AT ludvigssonjonasf esophagealabnormalitiesandtheriskforgastroesophagealcancersahistopathologyregisterbasedstudyinsweden
AT yinli esophagealabnormalitiesandtheriskforgastroesophagealcancersahistopathologyregisterbasedstudyinsweden
AT elbepeter esophagealabnormalitiesandtheriskforgastroesophagealcancersahistopathologyregisterbasedstudyinsweden
AT yeweimin esophagealabnormalitiesandtheriskforgastroesophagealcancersahistopathologyregisterbasedstudyinsweden